Concepedia

Alexandra Eyzaguirre

AE

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

2006

Affiliations

Louis Stokes Cleveland VA Medical Center(Current)

Alexandra Eyzaguirre is an author at Louis Stokes Cleveland VA Medical Center specializing in cell signaling, oncology, and molecular oncology.

Publications per year

2006–2010

7

Publications

7

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors

Elizabeth Buck, Alexandra Eyzaguirre, Eric Brown et al. · Molecular Cancer Therapeutics · 2006 · 234 citations

Life Sciences, Oncology, Pharmacology +17

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak et al. · Molecular Cancer Therapeutics · 2010 · 218 citations

Medicine, Oncology, Pharmacology +17

Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors

Elizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin et al. · Cancer Research · 2008 · 209 citations · Full text

Medicine, Oncology, Pharmacology +17

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

Elizabeth Buck, Alexandra Eyzaguirre, Sharon Barr et al. · Molecular Cancer Therapeutics · 2007 · 189 citations

Life Sciences, Cell Biology, Oncology +17

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling <i>in vitro</i> and inhibits insulin-like growth factor-I receptor–dependent tumor growth <i>in vivo</i>

Qunsheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin et al. · Molecular Cancer Therapeutics · 2007 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7